These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28843624)

  • 1. Sorafenib stimulates human skin type mast cell degranulation and maturation.
    Mizukami Y; Sugawara K; Kira Y; Tsuruta D
    J Dermatol Sci; 2017 Dec; 88(3):308-319. PubMed ID: 28843624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophin-3 regulates mast cell functions in neonatal mouse skin.
    Metz M; Botchkarev VA; Botchkareva NV; Welker P; Tobin DJ; Knop J; Maurer M; Paus R
    Exp Dermatol; 2004 May; 13(5):273-81. PubMed ID: 15140017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme.
    Ito N; Sugawara K; Bodó E; Takigawa M; van Beek N; Ito T; Paus R
    J Invest Dermatol; 2010 Apr; 130(4):995-1004. PubMed ID: 20043013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids limit excessive mast cell maturation and activation in human skin.
    Sugawara K; Bíró T; Tsuruta D; Tóth BI; Kromminga A; Zákány N; Zimmer A; Funk W; Gibbs BF; Zimmer A; Paus R
    J Allergy Clin Immunol; 2012 Mar; 129(3):726-738.e8. PubMed ID: 22226549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.
    Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F
    Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib induced eruptive melanocytic lesions.
    Uhlenhake EE; Watson AC; Aronson P
    Dermatol Online J; 2013 May; 19(5):18184. PubMed ID: 24011281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK
    Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
    Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
    Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
    Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
    Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway.
    Wygrecka M; Dahal BK; Kosanovic D; Petersen F; Taborski B; von Gerlach S; Didiasova M; Zakrzewicz D; Preissner KT; Schermuly RT; Markart P
    Am J Pathol; 2013 Jun; 182(6):2094-108. PubMed ID: 23562441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways.
    Sui X; Krantz SB; Zhao ZJ
    Br J Haematol; 2000 Jul; 110(1):63-70. PubMed ID: 10930980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis.
    Leconte M; Santulli P; Chouzenoux S; Marcellin L; Cerles O; Chapron C; Dousset B; Batteux F
    Reprod Sci; 2015 Sep; 22(9):1171-80. PubMed ID: 26169036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
    Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
    J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E
    Shichiri H; Yamamoto K; Tokura M; Ishida T; Uda A; Bito T; Nishigori C; Nakagawa T; Hirano T; Yano I; Hirai M
    Biochem Biophys Res Commun; 2017 Apr; 485(2):227-233. PubMed ID: 28237700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
    Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
    Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells.
    Lasithiotakis KG; Sinnberg TW; Schittek B; Flaherty KT; Kulms D; Maczey E; Garbe C; Meier FE
    J Invest Dermatol; 2008 Aug; 128(8):2013-23. PubMed ID: 18323781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress and Nasal Allergy: Corticotropin-Releasing Hormone Stimulates Mast Cell Degranulation and Proliferation in Human Nasal Mucosa.
    Yamanaka-Takaichi M; Mizukami Y; Sugawara K; Sunami K; Teranishi Y; Kira Y; Paus R; Tsuruta D
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation.
    Ceponis A; Konttinen YT; Takagi M; Xu JW; Sorsa T; Matucci-Cerinic M; Santavirta S; Bankl HC; Valent P
    J Rheumatol; 1998 Dec; 25(12):2304-14. PubMed ID: 9858422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway.
    Lessmann E; Grochowy G; Weingarten L; Giesemann T; Aktories K; Leitges M; Krystal G; Huber M
    Exp Hematol; 2006 Nov; 34(11):1532-41. PubMed ID: 17046573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells.
    Ishizuka T; Chayama K; Takeda K; Hamelmann E; Terada N; Keller GM; Johnson GL; Gelfand EW
    J Immunol; 1999 Feb; 162(4):2087-94. PubMed ID: 9973482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.